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Abstract. This paper describes the participation of master's students
(LITL programme, university of Toulouse) and their teachers to the
CLEF eHealth 2016 campaign. Two runs were submitted for task 2 (mul-
tilingual information extraction) which consisted in the recognition and
categorization of medical entities in French biomedical documents. The
system used consists of a CRF classiﬁer based on a number of diﬀerent
features (POS tagging, generic word lists and syntactic parsing). In addi-
tion, several patterns were used on the CRF's output in order to extract
more complex entities. The best run achieved high precision (0.640.78)
but lower recall (0.320.40), with an overall F1-measure of 0.430.53.
1 Introduction
This article describes the participation of the students of the LITL master to
the CLEF eHealth 2016 Lab [5].
LITL (stands for Linguistique, Informatique, Technologies du Langage, i.e.
Linguistics, IT, Language technologies) is a new master's program at the Univer-
sity of Toulouse, France. Mainly aimed at linguistics and humanities students, it
comprises, for a major part, courses in natural language processing (NLP), com-
putational linguistics and practical aspects of corpus analysis through program-
ming and using various computer tools. An important part of this curriculum is
project-oriented, and the ﬁrst year students have to build a fully operational pro-
cessing system for a precise NLP task. This year's project was the participation
to the CLEF eHealth challenge, more precisely task 2: multilingual Information
Extraction [10].
The teachers in charge of this project (members of the CLLE-ERSS labora-
tory) deemed that this task was ideal for pedagogical purposes:
 information extraction (and more precisely named entity recognition  NER)
is a well-known, well-deﬁned and central task in modern NLP;
 state of the art information extraction systems are based on machine learn-
ing techniques but can also make use of symbolic handcrafted rule-based
approaches;
 supervised learning systems such as CRF classiﬁers can take advantage of
diﬀerent kind of linguistic resources, many of these are available for the
biomedical domain;
 a collaborative task is an excellent exercise for students, as it motivates them
and gives them a clear feedback on their work;
 the target language of CLEF eHEalth 2016 is French, the students' working
language;
 the task's schedule was perfectly suited to the master's calendar.
Working as a team along the entire semester, the students were thus able
(with help from their teachers) to submit two runs for the selected task, and got
very satisfactory results for a ﬁrst attempt.
This paper is organized as follows. Section 2 describes the tasks and get a
closer look at the data. Section 3 gives a precise description of the diﬀerent
components of the system designed for the task, while the results are given and
discussed in Section 4.
2 Task description
2.1 Overview
The LITL team participation only concerns the CLEF 2016 eHealth task 2
phase 1 addressing biomedical NER in French texts. The aim is to automati-
cally detect and classify biomedical entities. Detection requires the system to
provide start and end positions of each relevant entities. The classiﬁcation step
consists in associating each previously detected entity with one of the ten target
categories corresponding to UMLS Semantic Group:
 Anatomy (ANAT),
 Chemical and Drugs (CHEM),
 Devices (DEVI),
 Disorders (DISO),
 Geographic Areas (GEOG),





Two text types are concerned with this task: drug inserts and biomedical
research papers' titles and (sub)headings. Biomedical entities cover a wide range
of linguistic expressions such as drug or city names, very common nouns (e.g.
"inﬁrmière" (nurse), "études" (studies)), technical specialized terms (e.g. "thy-
roglobuline", "électronystagmographie") or complex phrases (e.g. "infectés par le
virus de l'immunodéﬁcience humaine" (infected with human immunodeﬁciency
virus), "enfant âgé de plus de trois mois" (children over 3 months)).
2.2 Data
The training data set corresponds to the QUAERO French Medical Corpus [11]
previously used in CLEF 2015 eHealth task 1b [12] and made of two sub-corpora:
EMEA: 6 drug inserts written by the European Medicines Agency1 for the
general public ;
MEDLINE: 1665 titles and (sub)headings of biomedical academic papers in-
dexed in the MEDLINE database2.
Drug inserts are long texts (around 5,000 words/text on average) written in a less
specialized language than MEDLINE's very short text segments (6 words/item
on average), as illustrated in examples 1 from EMEA and 2 from MEDLINE,
see below. MEDLINE texts are written with an uncommon syntax, considering
that titles and (sub)headings usually correspond to noun phrases or non-ﬁnite
sentences without ﬁnal punctuation.
Example 1. Il est utilisé en association avec d ' autres médicaments antiviraux
dans le traitement des adultes et des enfants infectés par le virus
de l ' immunodéﬁcience humaine ( VIH ), le virus qui provoque le
syndrome d ' immunodéﬁcience acquise ( SIDA ). [EMEA/118_1]
Example 2. Hypersensibilité retardée dans les aﬀections thyroïdiennes étudiée par
le test de migration des leucocytes en présence de thyroglobuline hu-
maine . [MEDLINE/4573749]
Both sub-corpora have been manually annotated following similar guidelines
[11]. Each annotation is encoded in the BRAT standoﬀ annotation format3 and
includes for each entity an id, the relevant UMLS category, the oﬀset position
(start and end) and the textual content of the annotation. Example 3 gives the
manual annotations associated with example 2 and Figure 1 its visualization via
the BRAT annotation tool.
Example 3. T1 DISO 0 25 Hypersensibilité retardée
T2 DISO 0 16 Hypersensibilité
T3 DISO 35 59 affections thyroïdiennes
T4 DISO 35 45 affections
T5 ANAT 46 59 thyroïdiennes
T6 PROC 75 107 test de migration des leucocytes
T7 PHYS 83 107 migration des leucocytes
T8 PHYS 83 92 migration
T9 ANAT 97 107 leucocytes
T10 CHEM 123 137 thyroglobuline




Fig. 1. Visualization of annotated entities through BRAT
As for the detection subtask, annotated entities can be single words (77%)
or compounds (23%). Compound entities may be autonomous (e.g. "prise en
charge"); nested such as in (3) where "leucocytes" is nested in "migration des
leucocytes" which is in turn nested in "test de migration des leucocytes"; or
discontinuous such as "hépatites C" and "virus des hépatites C" in (4).
Example 4. Prévalence des marqueurs des virus des hépatites A , B ,
C à La Réunion ( Hôpital sud et prison de Saint Pierre ).
[MEDLINE/10774493]
T2 LIVB 29 34 virus
T5 DISO 39 48;57 58 hépatites C
T7 LIVB 29 48;57 58 virus des hépatites C
Table 1 gives an overview of the amount of annotated data per subset.
Table 1. Amount of annotated data per subset
Subset EMEA (%) MEDLINE (%) Total (%)
# of texts 6 1665 1671
# of words 28215 10503 38718
Annotated entities 4955 2977 7932
Compounds entities 995 20.1 846 28.5 1841 23.2
Discontinuous entities 42 0.8 21 0.7 63 0.8
Because discontinuous entities are very rare, we decided to not detect such
entities. Concerning nested entities which are more frequent, we implemented
post-processing as described in Section 3.
As for classiﬁcation subtask, entities are heterogeneously distributed among
ten types. Half of the annotated entities are categorized as DISO (26%) or CHEM
(25%). The rest spread mainly among PROC (16%), ANAT (11%) and LIVB (11%)
while types PHYS, OBJC, DEVI, GEOG and PHEN are fairly rare. When compound,
entities seem to be usually categorized as the ﬁrst (head) component (e.g. "virus
des hépatites C" is labeled LIVB as for "virus").
Preliminary linguistic observations of data reveal three main characteristics that
will constitute features for our system. First, the length of single-word anno-
tated entities (in characters) seems longer than non-annotated words with an
average of 9.5 characters against 5.5. Secondly, single-word entities show some
morphological complexity with a use of recurrent productive aﬃxes such as 
cyte, thérapie, endocrino, trachéo. Finally, annotated entities may be mainly
characterized as technical vocabulary in the biomedical domain especially for
main types (DISO and CHEM).
3 System description
In this section we present in details the system we designed for this task. Its
cornerstone is a Conditional Random Field (CRF) classiﬁer [6] that is used to
train a model based on the manually tagged datasets. Although CRFs are easily
applied thanks to readily available toolkits such as CRF++4, they require a
certain amount of preprocessing and are known to perform better when given
additional information on the tokens to analyze. Also, they cannot by themselves
provide all the solutions, especially when the target entities are nested and/or
overlap, that's why several post-processing procedures were necessary as well.
3.1 Overview
As is mandatory with machine learning supervised techniques, we ﬁrst had to
build a model based on the training data. This was done according to the scheme
presented in ﬁgure 2. As can be seen, this sequence starts with the raw text ﬁles
from the training dataset, corrects their tokenization, performs POS tagging and
syntactic parsing, then adds an additional set of features and ﬁnally provides,
along with the annotated ﬁles, input for the CRF training phase. The result is
a CRF model that can be used in the extraction phase.
The overall process used for extracting and categorizing entities from raw
text ﬁles can be seen in ﬁgure 3. We can see that it applies roughly the same
modules as for the training phase, but adds an additional post-processing step
after the CRF classiﬁer.
The stages are described in details in the following sections.
3.2 Preprocessing: correction, POS tagging and parsing
The ﬁrst set of modules concerns the processing of text ﬁles. The main role
of these modules is to provide a generic annotation layer for the tokens: POS
tagging, lemmatization and dependency parsing, as these additional information
are to be used by the CRF classiﬁer.
For both phases, we used the Talismane toolkit [13] for POS tagging and
dependency parsing, with the provided models for French and using the default
4 https://taku910.github.io/crfpp/
Fig. 2. System training phase
Fig. 3. Entities annotation phase
parameters. In addition to being a reliable tagger and dependency parser, Talis-
mane provides the oﬀset for each token, which is vital for dealing with the BRAT
standoﬀ annotation format.
The tokenization correction module has been developed in order to prevent
many tagging errors due to the non-standard blank spaces that appear in both
the training and test text ﬁles. The main problems were due to additional spaces
before and/or after commas, hyphens, apostrophes, periods, digits, etc. For ex-
ample, an extraneous space between "l" and the following apostrophe prevented
the tagger and parser from identifying a determiner. This correction module
is a simple Perl script using regular expressions to convert texts back to their
supposedly original punctuation, while keeping the additional spaces in order
to preserve the oﬀsets for the annotated and extracted entities. For example,
extract in (5) becomes (6) after correction:
Example 5. Par conséquent , lorsque vous serez traité par TYSABRI , vous ne constaterez 
peut-être pas d ' amélioration mais le traitement par TYSABRI pourra empêcher 
 l ' aggravation de votre maladie . [EMEA/425_6]
Example 6. Par conséquent,  lorsque vous serez traité par TYSABRI,  vous ne constaterez 
peut-être pas d'  amélioration mais le traitement par TYSABRI pourra empêcher 
 l'  aggravation de votre maladie.  
The output of the parser follows a column-based format, in which each token
is described on a separate line, as in the example (7) below (related to (5)), where
columns indicate, in order: word form, POS tag, lemma, syntactic dependency,
oﬀset.
Example 7. Par_conséquent ADV par_conséquent mod 1398
, PONCT , ponct 1413
lorsque CS lorsque mod 1415
vous CLS vous suj 1423
serez V être aux_pass 1428
traité VPP traiter sub 1434
par P par p_obj 1441
TYSABRI NPP _ prep 1445
, PONCT , ponct 1453
vous CLS vous suj 1455
ne ADV ne mod 1460
constaterez V constater root 1463
peut-être ADV peut-être mod 1475
pas ADV pas mod 1485
d' DET de det 1489
amélioration NC amélioration obj 1493
mais CC mais coord 1506
le DET le det 1511
traitement NC traitement suj 1514
par P par dep 1525
TYSABRI NPP _ prep 1529
pourra V pouvoir dep_coord 1537
empêcher VINF empêcher obj 1544
l' DET l' det 1553
aggravation NC aggravation obj 1557
de P de dep 1569
votre DET votre det 1572
maladie NC maladie prep 1578
. PONCT . ponct 1586
As can be seen, unknown tokens (i.e. absent from the reference lexicon used by
Talismane) have no corresponding lemma. We added correction procedure that
reproduces the word form instead of the "_" placeholder. The POS tags indicate
the token's nature (e.g. DETerminer, Verb, ADVerb, etc.) while the syntactic tag
indicate its function in the sentence, more precisely the relation it has with its
syntactic governor, such as object, modiﬁer, etc. Details on both tagsets can be
found in the Talismane documentation.
3.3 Adding features from external resources
In addition to the lemma, POS and syntactic relations, we added several features
we deemed relevant with the task (see 2). These features are the following:
 does the token appear in a speciﬁc word lists?
 what is the token's length in number of characters?
 does the token begin with a recognizable preﬁx?
 does the token end with a recognizable suﬃx?
These features and the way they were calculated are described in the following
paragraphs
Word lists
We used several word lists in order to extend the lexical coverage beyond
what is present in the training datasets. We used two main sources: SNOMED
and a list of commercial drug names.
SNOMED [14] is a well-known and used resource for biomedical NLP, as it
contains extensive word lists. We selected the 4 most relevant top categories,
and extracted all the single-word terms in each one.
As noted above (Section 2), manual observation of the training data (es-
pecially the EMEA subset) revealed that a large number of commercial names
of drug were present and systematically tagged as CHEM entities. Given that
SNOMED only contains scientiﬁc names of chemicals, we wanted to use an ad-
ditional resource to tag these speciﬁc tokens, as performed by several named
entities recognition systems [8]
We used the Vidal website5, which is the reference compendium for pharma-
ceutical drugs in France. After downloading the list of raw drug names it pro-
vides, we developed an adhoc Perl script that identiﬁes the main name through
removal of extraneous information such as posology indications (i.e. transforming
"ABSTRAL 100 µg cp subling" into "Abstral").
Table 2 gives the number of terms used and a few examples for each of the
selected 5 categories.
Table 2. Word lists extracted from SNOMED resource and VIDAL database
Category Nb of terms Examples
SNOMED Chimie (chem) 3505 toxine, magnésium, métoxyphénamine
SNOMED Morphologie (morph) 1033 microfracture, antéﬂexion, hypomyélinisation
SNOMED Procédure (proc) 62 cystométrogramme, électronystagmographie, thérapie
SNOMED Agents physiques (phys) 378 garrot, oxymètre, hémocytomètre
VIDAL drug names (chem) 3873 aspirine, nicopatch, ventoline
In the end, each token is then associated with a tag (column) containing the
SNOMED/VIDAL category (chem, morph, proc or phys) if its lemma appears
in the corresponding word list, or none in other cases.
Token length
As noted above from an observation of the training data, word length can
be a good indicator for biomedical terms. Given that the CRF classiﬁer cannot
deal with numerical feature, we used a qualitative measure of the length using
the following scale: short < 6 ≤ medium < 10 ≤ long .
Aﬃxes
Two additional features based on aﬃxes were designed in order to help tech-
nical specialized vocabulary detection. It is well known that biomedical technical
5 http://www.vidal.fr
terms are extensively coined through the use of standard suﬃxes and preﬁxes.
Identifying these can be a useful addition to the necessarily limited reference
word lists for entity recognition [8, 9]. We thus compiled lists of French preﬁxes
and suﬃxes. We relied on existing lists (most of them seemingly compiled for
the training of medicine students):
 Lexique des racines, préﬁxes et suﬃxes des termes scientiﬁques et médicaux
by D. Pol, found at http://www.didier-pol.net/
 Lexique des aﬃxes (préﬁxes et suﬃxes) by A. Abbara, found at http://
www.aly-abbara.com/litterature/medicale/affixes/a.html
 Terminologie médicale : préﬁxes et suﬃxes by P. Cauwel, found at https://
sites.google.com/site/cauwelphilippe/Home/terminologie-medicale-prefixes-et-suffixes
Once merged, these lists provided 394 preﬁxes and 126 suﬃxes.
For each token, the longest preﬁx (resp. suﬃx) in the list matching its lemma
was used as an additional tag, and none when no match could be found.
3.4 From BRAT to BIO: selection of entities from the training set
Viewing the task of entity recognition and categorization as a tagging task re-
quires the data (both training and testing) to be transformed into a compatible
scheme. If the BRAT standoﬀ annotation format is perfect for the visualization
and declaration of these entities, it is not appropriate for an automated tagging
process.
The BIO format is traditionally used for expressing token sequences such as
chunks or named entities (cf. [3, 1, 2] for NER in biomedical texts). Its principle
is the following: each token in a text can be at the Beginning, Inside or Outside an
entity. Because entity categorization must be performed, the B (resp. I) letter is
completed by the name of the entity's category. For example, to express the fact
that "Hypersensibilité retardée" is a DISO we tag "Hypersensbilité" as DISO_B
and "retardée" as DISO_I.
Thus deﬁned, the task for the CRF classiﬁer is to tag each token with one
of the 21 possible value (there are 10 target entity categories, so 10 X_B and 10
X_I, but only one O). This task is thus formally similar to other NLP tagging
tasks such as POS tagging, where a target value has to be decided according to
the descriptive features of the token (and, in the case of CRF, to the features
and values of the neighboring tokens).
An alternative scheme is known as BILOU and adds the possibility for a
token to be the Last token or to be the Unique one for this entity (cf. [4] for
NER in biomedical domain). Although more precise, its main disadvantage is to
increase the number of possible tags (41 in our case), making it harder for the
classiﬁer and generally requiring a larger amount of training data in order to be
reliable (see [7] for a comparison between BIO and BILOU scores).
However, none of these schemes is able to faithfully represent nested, over-
lapping or discontinuous entities. As noted above, in section 2 (example 3),
"Hypersensibilité retardée" contains two entities: "Hypersensibilité" and "Hy-
persensibilité retardée". Both are of the DISO category, and both begins with
the word "Hypersensibilité". However, only one of them can be represented using
the BIO format. The same goes for more complex situations like the sequence
"test de migration des leucocytes", still in example 3.
A decision had to be made when translating the annotated entities into the
BIO format: do we keep the longest entities or the shortest? More precisely,
do we consider "leucocytes" to be an ANAT entity by itself (thus receiving an
ANAT_B tag) or part of the PHYS entity "migration des leucocytes" (with an
PHYS_I tag)? This decision impacts the whole process, as what is decided for
the training phase of the CRF will of course directly inﬂuence what is produced
in the tagging phase.
This dilemma could be summarized as a choice between fewer but more
complex entities versus more small ones. We decided to choose the latter, as we
deemed it easier to "rebuild" complex entities from smaller ones than the other
way around.
At this stage, each text is represented by a set of features available for each
token, along with a BIO tag for the training data, as is the case in example (8)
derived from (7):
Example 8.
Par_conséquent ADV par_conséquent mod 1398 long none none none O
, PONCT , ponct 1413 short none none none O
lorsque CS lorsque mod 1415 medium none none none O
vous CLS vous suj 1423 short none none none O
serez V être aux_pass 1428 short none none none O
traité VPP traiter sub 1434 medium none none none PROC_B
par P par p_obj 1441 short none none none O
TYSABRI NPP TYSABRI prep 1445 medium none none chem CHEM_B
, PONCT , ponct 1453 short none none none O
vous CLS vous suj 1455 short none none none O
ne ADV ne mod 1460 short none none none O
constaterez V constater root 1463 long con none none O
peut-être ADV peut-être mod 1475 medium none none none O
pas ADV pas mod 1485 short none none none O
d' DET de det 1489 short none none none O
amélioration NC amélioration obj 1493 long none tion none O
mais CC mais coord 1506 short none none none O
le DET le det 1511 short none none none O
traitement NC traitement suj 1514 medium none ment none PROC_B
par P par dep 1525 short none none none O
TYSABRI NPP TYSABRI prep 1529 medium none none chem CHEM_B
pourra V pouvoir dep_coord 1537 medium none none none O
empêcher VINF empêcher obj 1544 medium none none none O
l' DET l' det 1553 short none none none O
aggravation NC aggravation obj 1557 long none tion none O
de P de dep 1569 short none none none O
votre DET votre det 1572 short none none none O
maladie NC maladie prep 1578 medium none none none DISO_B
. PONCT . ponct 1586 short none none none O
3.5 CRF templates and parameters
As noted above, we chose to use a CRF classiﬁer (CRF++) in order to predict
the BIO tag for each token given the features described in the previous sections.
Training the CRF requires to deﬁne a template, i.e. a selection of which pieces of
information are given as an input to the model. The speciﬁcity of CRF systems
is that they can take into account both the features associated to the target
token and the ones of its neighbors. Thus, a template is used to deﬁne which
feature(s) of which neighbor(s) are used.
In summary, after a number of trial runs using the training data, we opted
for the following:
 word form of target token and of the tokens appearing in a size-2 window
around it;
 POS tag of target token and of the tokens appearing in a size-2 window
around it;
 length, preﬁx, suﬃx, and presence in word lists of the target token;
 BIO tag attributed to the previous token.
Moreover, the second run submitted uses the syntactic dependency tag of the
target token, in addition to the previous features. This decision followed a ﬁrst
experiment to evaluate the contribution of each diﬀerent features. The system
evaluation was conducted by using the original train/devel split provided for the
training data. Table 3 gives some results of a lesion studies, i.e. indicating for
each feature how their removal from the template aﬀects the task system's per-
formances. F-scores were calculated by using the BRATeval.jar script provided
by the organizers (exact matching option on true). As table 3 shows, syntac-
Table 3. Features contribution: F1 variation when feature is removed
F1-score EMEA MEDLINE
All features 0.5429 0.3821
- Syntactic relations -0.0003 +0.0046
- Token length +0.0109 -0.0038
- Aﬃxes -0.0085 -0.0227
- SNOMED and drugs lexicon -0.0116 -0.0340
tic feature contribution depends on the syntactic characteristics of texts: when
texts have uncommon syntax as for MEDLINE items (see 2), using the syntactic
information may worsen results. All other features have a positive contribution
to the model for both target subsets, and thus has been kept in the system.
We considered separating the training subsets (EMEA and MEDLINE) and
creating diﬀerent models, but experiments in this direction were inconclusive, so
we decided to use all the training data as a whole and to use the same model
for both test subsets.
3.6 From BIO to BRAT: identifying complex named entity  NE
The ﬁnal stage of the tagging phase is the translation from the BIO format
back to the target BRAT standoﬀ annotation format. Beyond simple format
conversion, the main problem here is the reconstruction of entities, assuming
the choices made in the training phase and addressing the limitations of the
BIO format.
This stage is performed in two steps. The ﬁrst one is a simple identiﬁcation of
entities, blindly following the BIO format. It means that, for each token tagged
as XXX_B we extract one (and only one) entity, comprising the initial tokens along
with all following tokens tagged as YYY_I. For example, we extract "hyperplasie
focale modulaire" as a single DISO entity from the following output:
Example 9. hyperplasie (NC) DISO_B
focale (ADJ) DISO_I
modulaire (ADJ) DISO_I
In case of inconsistency between the categories (i.e. if XXX is diﬀerent from
YYY), we attribute the initial (XXX) category to the NEs.
As explained above, the choices made initially imply that at this stage we
only get non-nested entities, although most of the time they are parts of larger
entities. For example, given the following sequence in the CRF output:
Example 10. tuberculose (NC) DISO_B
médiastinale (ADJ) ANAT_B
the ﬁrst step extracts two separate entities: "tuberculose" as a DISO and
"médiastinale" as a ANAT. In order to extract some of the more complex entities,
we designed a few extraction patterns, based on the POS tags. The ﬁrst pattern
looks for a noun tagged as B, followed by an adjective tagged as B, i.e. the
exact situation found in the example 10. Its output is the concatenation of both
tokens, tagged with the category of the head noun. This means that this patterns
produces "tuberculose médiastinale" as a DISO.
Similar patterns have been designed for longer sequences of adjectives: NC
(B) ADJ (B) ADJ (B or I), and for nominal compounds such as NC (B) de/du/des/au/aux
NC (B) and NC (B) P DET NC (B).
All extracted entities are collected in the BRAT standoﬀ annotation format
as noted above. The oﬀsets are immediately available thanks to Talismane output
format and the content of the entity is a simple concatenation of their tokens'
word forms.
4 Results and discussion
In this last section we present and discuss the results obtained by our system on
the task's test data.
4.1 Main results
As indicated in Table 4, our F1 scores are above the average (of submitted runs)
for entity recognition in EMEA and slightly under it for MEDLINE with, for
all subsets, a high precision and a low recall. The non-exact matching scoring
procedure means that the oﬀsets of the entities can partially overlap instead
of being perfectly aligned. Run1 (without syntactic feature) and run2 (with
Table 4. LITL team scores on test data. For both target data and for each run,
number of true positives (TP), fase positives (FP) and false negatives (FN), along with
recall, precision and F1 scores, with exact and non-exact matching. Average scores were
computed on all submitted runs.
EMEA exact matching no exact matching
TP FP FN Precision Recall F1 TP FP FN Precision Recall F1
LITL-run1 879 242 1325 0.7841 0.3988 0.5287 990 131 1069 0.8831 0.4808 0.6226
LITL-run2 867 264 1337 0.7666 0.3934 0.5199 995 136 1052 0.8798 0.4861 0.6262
Average scores 0.5250 0.4114 0.4350 0.6377 0.5141 0.5423
MEDLINE exact matching no exact matching
TP FP FN Precision Recall F1 TP FP FN Precision Recall F1
LITL-run1 998 556 2105 0.6422 0.3216 0.4286 1247 307 1531 0.8024 0.4489 0.5757
LITL-run2 989 561 2114 0.6381 0.3187 0.4251 1237 313 1544 0.7981 0.4448 0.5712
Average scores 0.5030 0.4264 0.4455 0.6387 0.5707 0.5859
syntactic feature) scores show little diﬀerences as expected, although run 1 gets
higher scores for both subsets with exact matching. The order is partly diﬀerent
without exact matching where run2 gest slightly higher results for EMEA only.
It should be noted that matching option only concerns entity delimitation and
not disagreement on entity classiﬁcation.
A closer look at the scores per category shows that we get the highest per-
formance on EMEA texts for LIVB entities recognition with a 0.86 F1 (0.93 P
and 0.8 R, 268 entities), followed by PROC (0.7 F1, 269 entities) and CHEM (0.67
F1, 885 entities). The detection of DISO entities, which cover the largest part of
biomedical entities (988 entities in MEDLINE and 342 in EMEA), is better in
MEDLINE texts (0.66 F1) than in EMEA texts (0.57 F1).
4.2 Test data set overview and errors observation
To better understand our system weaknesses, we propose a quick observation of
the test dataset, then an overview of the false negatives (FN) and false positives
(FP). First of all, an overview of test data reveals a diﬀerence from the training
data that may explain some of our FN. Indeed, as indicated in table 5, while the
proportion of compounds is approximatively the same than in training data set,
Table 5. Quantitative overview of test data set
Subset EMEA (%) MEDLINE (%) Total (%)
# of texts 4 833 1671
# of words 12042 10871 22913
Annotated entities 2070 3150 5220
Compound entities 499 24.1 886 28.1 1385 26.5
Discontinuous entities 42 2.0 23 0.7 65 1.2
the proportion of discontinuous entities  which were not taken into account by
our system  is double.
If we take a closer look at FP and FN, we may distinguish several cases (all
subsequent examples come from the EMEA subset). First, FPs may be due to
a disagreement on entity category such as the CHEM polydextrose or diacétate de
glycérol which our system both classiﬁed as DISO. A comparison between run1
and the gold standard shows 187 cases of such miscategorization (60 in EMEA
and 127 in MEDLINE), with quite a lot of confusions about subtle distinctions
such as between OBJC  physical objects and DEVI  devices or between PROC 
procedures and CHEM  chemical and drugs. As for example, in (11), "injection"
was automatically categorized PROC instead of CHEM and "seringue" (syringe)
was automatically categorized OBJC instead of DEVI.
Example 11. L ' injection sous-cutanée est réalisée de la même façon qu ' avec
une seringue classique .[EMEA/334_3]
The subcutaneous injection must be conducted in the same way as with
a classical syringe
Classiﬁcation errors may also be linked with polysemy as for example with the
word "bouton" which means either a concrete object (button) or an anatomic/physiological
entity (pimple).
A second group of FPs may be linked to the well-known problem of dis-
tinguishing between specialized vs. common usages. Such cases occur when a
common word or compound was incorrectly recognized as biomedical entities
(e.g. "anomalies" recognized as DISO or "Mélange de couleur bleu" as CHEM).
A last possible explanation for FPs is related to compounds boundaries as
for example when a CHEM is syntactically linked to a LIVB but not manually
annotated as a compound (e.g. "olanzapine chez les enfants" or "olanzapine
sur les protéines"). Same mistakes may be observed due to prepositional phrase
attachment ambiguity as for example in (12)
Example 12. Traitement de l' ankylostomiase par le tétrachloréthylène chez l'
adulte et le grand enfant . [MEDLINE/13515790]
where our system recognized "ankylostomiase par le tétrachloréthylène" as a
DISO because of the pattern NC (B) P DET NC (B) whereas th prepositional
phrase "par le tétrachloréthylène" is syntactically attached to "Traitement" and
not to "ankylostomiase".
Moreover, when exact matching, other FPs may be observed such as "troubles
hématologiques périphériques" detected as a single entity instead of two entities
"troubles hématologiques" and "périphériques".
This compound boundaries problem has very strong consequences on recall
and may explain the large amount of FNs (more than 1,300 in EMEA and
2,100 in MEDLINE, see Table 4). Indeed, when "troubles hématologiques pé-
riphériques" is detected instead of two entities "troubles hématologiques" and
"périphériques", it causes one FP and two FNs. A simple way for dealing with
this problem will be to systematically split detected compounds into as many
single entities as single words.
The converse is also observed i.e. when our system extracts only one term
from a compound, as for example "Olanzapine Teva" manually annotated as
CHEM while our system recognized only "Olanzapine" and not "Teva". Such FNs
were essentially due to the limited coverage of our external resources.
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